ABOUT THE PRODUCT
AavantiBio’s core offering is a proprietary gene therapy platform utilizing adeno-associated viruses (AAVs) to deliver therapeutic genes to target cells. This platform is currently focused on developing treatments for Friedreich’s Ataxia and other rare genetic diseases.
Information is owner-confirmed
Last updated 2 weeks ago
Price range
Other products/services from AavantiBio, Inc.
Gene Therapy Research Services
Biotechnology
N/A
AavantiBio, Inc.
United States (US)